The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs

The Trump administration has decided to end a Medicare drug subsidy program in 2027 that had been keeping prescription drug costs lower for seniors. This move could lead to higher monthly costs for millions of older adults with Medicare drug coverage, creating tension with the administration's stated goal of reducing drug prices.